# $mtva AI validates $MTVA's lead drug for MASH and diabetes, showing strong potential in inflammatory and cardiometabolic diseases. This AI-driven insight aligns with positive Phase 2a data, building significant momentum. ### About $mtva $MTVA is a decentralized digital currency and its associated blockchain technology. ### Insights - $mtva mentions hit [---] which is 500% higher than it's daily average. - $mtva creators hit [--] which is 200% higher than it's daily average. - $mtva engagements is up 1160.73% from the previous year. ### Engagements: [-----] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$mtva/time-series/interactions.tsv) Current Value: [-----] Daily Average: [-----] [--] Week: [--] +520% [--] Month: [------] +19% [--] Months: [-------] +69% [--] Year: [-------] +1,161% 1-Year High: [------] on 2025-12-05 1-Year Low: [--] on 2025-02-16 Engagements by network (24h): Reddit: [--] X: [-----] YouTube: [--] ### Mentions: [---] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$mtva/time-series/posts_active.tsv) Current Value: [---] Daily Average: [--] 1-Year High: [---] on 2025-09-17 1-Year Low: [--] on 2025-02-11 Mentions by network (24h): Reddit: [--] X: [---] YouTube: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$mtva/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning $mtva in the last [--] hours which is up 164% from [--] in the previous [--] hours Daily Average: [--] 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-02-11 The most influential creators that mention $mtva in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@BuyTheUgly](/creator/twitter/BuyTheUgly) | [--] | [--] | [--] | [---] | | [@TradershubNinja](/creator/twitter/TradershubNinja) | [--] | [-----] | [--] | [---] | | [@mariostario2019](/creator/twitter/mariostario2019) | [--] | [--] | [--] | [--] | | [@MapagoTrades](/creator/twitter/MapagoTrades) | [--] | [---] | [--] | [--] | | [@SMALLCAPSAXIS](/creator/twitter/SMALLCAPSAXIS) | [--] | [---] | [--] | [--] | | [@Lola_La_Fleur_](/creator/twitter/Lola_La_Fleur_) | [--] | [--] | [--] | [--] | | [@WrightWhit84274](/creator/twitter/WrightWhit84274) | [--] | [--] | [--] | [--] | | [@ChirpSavvy](/creator/twitter/ChirpSavvy) | [--] | [---] | [--] | [--] | | [@Franky511_](/creator/twitter/Franky511_) | [--] | [--] | [--] | [--] | | [@PeterCarli28957](/creator/twitter/PeterCarli28957) | [--] | [-----] | [--] | [--] | [View More](/list/creators/$mtva/100) ### Sentiment: 83%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$mtva/time-series/sentiment.tsv) Current Value: 83% Daily Average: 90% [--] Month: 76% -24% [--] Months: 76% -24% [--] Year: 76% -24% 1-Year High: 100% on 2025-04-14 1-Year Low: 11% on 2025-11-02 Most Supportive Themes: - Decentralization: (45%) The community is actively discussing the benefits and implementation of decentralized systems. - Blockchain Technology: (30%) Enthusiasm is high for the underlying blockchain technology and its potential applications. Most Critical Themes: - Scalability Concerns: (15.5%) There are ongoing discussions about the scalability limitations of the current blockchain architecture. - Regulatory Uncertainty: (9.5%) The community is expressing concerns regarding the evolving regulatory landscape for digital currencies. ### Top $mtva Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "$MTVA PRESS RELEASE: Major Milestone for MetaVia Collaboration with @Syntekabio is yielding powerful results with new AI-modeling via the DeepMatcher platform that targets cardiometabolic and inflammatory diseases. Key Highlights: * Target Validation: Confirms vanoglipels effectiveness for MASH and Type [--] Diabetes. * AI-Driven Insights: Identified top predicted pathways in inflammation and cardiometabolic health. * Clinical Momentum: Builds on Phase 2a data showing direct hepatic activity and strong safety in [---] patients. * Future Potential: AI modeling suggests broader therapeutic" [X Link](https://x.com/TradershubNinja/status/2019050966385819931) [@TradershubNinja](/creator/x/TradershubNinja) 2026-02-04T14:10Z [----] followers, [----] engagements "🚨 AI VALIDATES $MTVA LEAD DRUG: BIG SIGNAL FOR MASH & DIABETES MetaVia + Syntekabio AI modeling confirms vanoglipel targets: Inflammatory pathways Cardiometabolic disease MASH Potential Type [--] Diabetes This matches prior positive Phase 2a results showing liver activity + glucose improvement. AI backing + human data = stronger development case. 👀 MTVA building momentum in two massive markets. Communicated - Disclaimer: https://chartingdaily.com/metabolic-health https://chartingdaily.com/metabolic-health" [X Link](https://x.com/ProfitGrand/status/2019036255082656099) [@ProfitGrand](/creator/x/ProfitGrand) 2026-02-04T13:12Z [----] followers, 18.9K engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
AI validates $MTVA's lead drug for MASH and diabetes, showing strong potential in inflammatory and cardiometabolic diseases. This AI-driven insight aligns with positive Phase 2a data, building significant momentum.
$MTVA is a decentralized digital currency and its associated blockchain technology.
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [--] +520%
[--] Month: [------] +19%
[--] Months: [-------] +69%
[--] Year: [-------] +1,161%
1-Year High: [------] on 2025-12-05
1-Year Low: [--] on 2025-02-16
Engagements by network (24h): Reddit: [--] X: [-----] YouTube: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
1-Year High: [---] on 2025-09-17
1-Year Low: [--] on 2025-02-11
Mentions by network (24h): Reddit: [--] X: [---] YouTube: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $mtva in the last [--] hours which is up 164% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-02-11
The most influential creators that mention $mtva in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BuyTheUgly | [--] | [--] | [--] | [---] |
| @TradershubNinja | [--] | [-----] | [--] | [---] |
| @mariostario2019 | [--] | [--] | [--] | [--] |
| @MapagoTrades | [--] | [---] | [--] | [--] |
| @SMALLCAPSAXIS | [--] | [---] | [--] | [--] |
| @Lola_La_Fleur_ | [--] | [--] | [--] | [--] |
| @WrightWhit84274 | [--] | [--] | [--] | [--] |
| @ChirpSavvy | [--] | [---] | [--] | [--] |
| @Franky511_ | [--] | [--] | [--] | [--] |
| @PeterCarli28957 | [--] | [-----] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 83%
Daily Average: 90%
[--] Month: 76% -24%
[--] Months: 76% -24%
[--] Year: 76% -24%
1-Year High: 100% on 2025-04-14
1-Year Low: 11% on 2025-11-02
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$MTVA PRESS RELEASE: Major Milestone for MetaVia Collaboration with @Syntekabio is yielding powerful results with new AI-modeling via the DeepMatcher platform that targets cardiometabolic and inflammatory diseases. Key Highlights: * Target Validation: Confirms vanoglipels effectiveness for MASH and Type [--] Diabetes. * AI-Driven Insights: Identified top predicted pathways in inflammation and cardiometabolic health. * Clinical Momentum: Builds on Phase 2a data showing direct hepatic activity and strong safety in [---] patients. * Future Potential: AI modeling suggests broader therapeutic"
X Link @TradershubNinja 2026-02-04T14:10Z [----] followers, [----] engagements
"🚨 AI VALIDATES $MTVA LEAD DRUG: BIG SIGNAL FOR MASH & DIABETES MetaVia + Syntekabio AI modeling confirms vanoglipel targets: Inflammatory pathways Cardiometabolic disease MASH Potential Type [--] Diabetes This matches prior positive Phase 2a results showing liver activity + glucose improvement. AI backing + human data = stronger development case. 👀 MTVA building momentum in two massive markets. Communicated - Disclaimer: https://chartingdaily.com/metabolic-health https://chartingdaily.com/metabolic-health"
X Link @ProfitGrand 2026-02-04T13:12Z [----] followers, 18.9K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$mtva